News coverage of the long-awaited session of this week’s American Heart Association’s scientific meetings that had promised to constructively address uncomfortable issues surrounding recent statin clinical trials is virtually nowhere to be found. There was no AHA press release and only one reporter even covered it at all. The session — “What Is the Emperor Wearing? Unbiased Evidence from